•• Mullol J, Mariño-Sánchez F, Valls M, Alobid I, Marin C. The sense of smell in chronic rhinosinusitis. J Allergy Clin Immunol. 2020;145:773–6. Loss of smell is one of the predominant symptoms in chronic rhinosinusitis, being a key predictor of reduced quality of life.
Marin C, Hummel T, Liu Z, Mullol J. Chronic rhinosinusitis and COVID-19. J Allergy Clin Immunol Pract. 2022;10:1423–32.
Article CAS PubMed Google Scholar
Stevens WW, Peters A, Tan BK, Klingler A, Poposki JA, Hulse KE, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Aller Clin Immunol Pract. 2019;7:2812–20.
Leung CT, Coulombe PA, Reed RR. Contribution of olfactory neural stem cells to tissue maintenance and regeneration. Nat Neurosci. 2007;10:720–6.
Article CAS PubMed Google Scholar
•• Schwob JE, Jang W, Holbrook EH, Lin B, Herrick DB, Peterson JN, et al. Stem and progenitor cells of the mammalian olfactory epithelium: Taking poietic license. J Comp Neurol. 2017;525:1034–54. Description of the robust capacity of the olfactory epithelium to replenish olfactory neurons lost throughout life to maintain ongoing neurogenesis during adult life.
Article CAS PubMed Google Scholar
Holbrook EH, Wu E, Curry WT, Lin DT, Schwob JE. Immunohistochemical characterization of human olfactory tissue. Laryngoscope. 2011;121:1687–701.
Article CAS PubMed Google Scholar
•• Rouyar A, Classe M, Gorski R, Bock MD, Le-Guern J, Roche S, et al. Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis model. Allergy. 2019;549–59. Alteration of neurogenesis induced by type 2 inflammation.
•• Chen M, Reed RR, Lane AP. Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell Stem Cell. 2019;25:501–13. Olfactory stem basal cells in the olfactory mucosa are activated triggering a functional switch from a neuro-regenerative phenotype to one contributing to immune defense in an animal model of inflammation and in chronic rhinosinusitis patients.
Article CAS PubMed Google Scholar
Rustenhoven J, Kipnis J. Smelling danger: olfactory stem cells control immune defense during chronic inflammation. Cell Stem Cell. 2019;25:449–51.
Article CAS PubMed Google Scholar
Bryche B, Baly C, Meunier N. Modulation of olfactory signal detection in the olfactory epithelium: focus on the internal and external environment, and the emerging role of the immune system. Cell Tissue Res. 2021;384:589–5.
Lakshmanan HG, Miller E, White-Canale A, McCluskey LP. Immune responses in the injured olfactory and gustatory systems: a role in olfactory receptor neuron and taste bud regeneration? Chem Senses. 2022;47:1–19.
Imamura F, Hasegawa-Ishii S. Environmental toxicants-induced immune responses in olfactory mucosa. Front Immunol. 2016;7:475.
Wellford SA, Moseman EA. Olfactory immune response to SARS-CoV-2. Cell Mol Immunol. 2024;21:134–43.
Article CAS PubMed Google Scholar
Fokkens WJ, LundVJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2020;58:1–464.
Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong A, et al. International consensus statement on rhinology and allergy: rhinosinusitis. Int Forum Aller Rhinol. 2021;11:213–39.
Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA. Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era. J Aller Clin Immunol Pract. 2022;10:1434–53.
Kato A, Schleimer RP, Bleier BS. Mechanisms and pathogenesis of chronic rhinosinusitis. J Aller Clin Immunol. 2022;149:1491–503.
Kowalski ML, Agache I, Bavbek S, Bakirtas A, Blanca M, Bochenek G, et al. Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy. 2019;74:8–39.
Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Aller. 2021;14:127–34.
Article CAS PubMed Google Scholar
Tokunaga T, Sakashita M, Haruna T, Asaka D, Takenno S, Ikeda H, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study. Allergy. 2015;70:995–3.
Article CAS PubMed Google Scholar
Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74:2312–9.
Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, et al. Position paper on olfactory dysfunction. Rhinology Suppl. 2017;54:1–30.
Kohli P, Naik AN, Harruff EE, Nguyen SA, Schlosser RJ, Soler ZM. The prevalence of olfactory dysfunction in chronic rhinosinusitis: olfactory dysfunction in chronic sinusitis. Laryngoscope. 2017;127:309–20.
Macchi A, Giorli A, Cantone E, Pipolo GC, Arnone F, Barbone U, et al. Sense of smell in chronic rinosinusitis: a multicentric study on 811 patients. Front Aller. 2023;4:1083964.
Simopoulos E, Katomichelakis M, Gouveris H, Tripsianis G, Livaditis M, Danielides V. Olfaction-associated quality of life in chronic rhinosinusitis: adaption and validation of an olfaction-specific questionnaire. Laryngoscope. 2012;122:1450–4.
Chung JH, Lee YJ, Kang TW, Kim KR, Jang DP, Kim IY, et al. Altered quality of life and psychological health (SCL-90-R) in patients with chronic rhinosinusitis with nasal polyps. Ann Otol Rhinol Laryngol. 2015;124:663–70.
Passali GC, Passali D, Cingi C, Ciprandi G. Smell impairment in patients with chronic rhinosinusitis: a real-life study. Eur Arch Otorhinolaryngol. 2022;279:773–7.
Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life-an updated review. Chem Senses. 2014;39:185–94.
•• Litvack JR, Mace JC, Smith TL. Olfactory function and disease severity in chronic rhinosinusitis. Am J Rhinol Aller. 2009;23:139–44. Loss of smell in chronic rhinosinusitis correlates with disease severity.
Mullol J, Bachert C, Amin N, Desroisers M, Hellings PW, Han JK, et al. Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps. J Aller Clin Immunol Pract. 2022;10:1086–95.
Mattos JL, Rudmik L, Schlosser RJ, Smith TL, Mace JC, Alt J, et al. Symptom importance, patient expectations, and satisfaction in chronic rhinosinusitis. Int Forum Aller Rhinol. 2019;9:593–6.
Haxel BR. Recovery of olfaction after sinus surgery for chronic rhinosinusitis: a review. Laryngoscope. 2019;129:1053–9.
Schlosser RJ, Mulligan JK, Hyer JM, Karnezis TT, Gudis DA, Soler ZM. Mucous cytokine levels in chronic rhinosinusitis-associated olfactory loss. JAMA Otolaryngol-Head Neck Surg. 2016;142:731–7.
Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128:E304–10.
Article CAS PubMed Google Scholar
•• Soler ZM, Yoo F, Schlosser RJ, Mulligan J, Ramakrishnana VR, Beswick DM, et al. Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Aller Rhinol. 2020;10: 343–55. In chronic rhinosinusitis with nasal polyps (CRSwNP) patients, elevated levels of Th2-driven proinflammatory cytokines in the mucus collected from the olfactory cleft have been associated with reduced scores for smell test identification.
Saraswathula A, Liu MM, Kulaga H, Lane AP. Chronic interleukin-13 expression in mouse olfactory mucosa results in regional aneuronal epithelium. Int Forum Aller Rhinol. 2023;13:230–41.
Lavin J, Min JY, Lidder AK, Huang JH, Kato A, Lam K, et al. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients. Laryngoscope. 2017;127:2210–8.
Article CAS PubMed Google Scholar
Wu D, Li Y, Bleier BS, Wei Y. Superior turbinate eosinophilia predicts olfactory decline in patients with chronic rhinosinusitis. Ann Aller Asthma Immunol. 2020;125:304–10.
Jaume F, Quintó L, Alobid I, Mullol J. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 2018;8:e018788.
Article PubMed PubMed Central Google Scholar
Stjärne P, Odelbäck P, Ställberg B, Lundberg J, Olsson P. High costs and burden illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care. Prim Care Respir J. 2012;21:174–9.
Jaume F, Valls-Mateus M, Mullol J. Common cold and acute rhinosinusitis: up-to-date management in 2020. Curr Aller Asthma Rep. 2020;20:28.
•• Staudacher AG, Peters AT, Kato A, Stevens WW. Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis. Ann Aller Asthma Immunol. 2020;124:318–25. Description of the three inflammatory endotypes (type 1, type 2, and type 3) and their biomarkers.
Seiden AM. Postviral olfactory loss. Otolaryngol Clin North Am. 2004;37:1159–66.
Liu ZY, Vaira LA, Bosccolo-Rizzo P, Walker A, Hopkins C. Post-viral olfactory loss and parosmia BMJMED. 2023;2:e000382.
留言 (0)